Omemyl (Omeprazole)

Omemyl is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): Provides relief of heartburn and promotes healing of esophageal erosion.
• Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with the condition.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, inhibiting the final step of acid production. This suppression of gastric acid secretion lowers gastric pH, allowing damaged mucosa to heal and reducing irritation from acid exposure.

Adverse reactions to Omeprazole may vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: typically self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: occasional bowel habit change.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: signs of hepatic stress.
• Acute interstitial nephritis: kidney inflammation.

When using Omemyl, consider the following precautions:

• Assess renal function: dose adjustment may be needed in severe renal impairment.
• Evaluate hepatic function: use with caution in patients with liver disease.
• Monitor long‑term use: prolonged therapy may increase fracture risk.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Pregnancy and lactation: weigh benefits against potential risks; consult healthcare provider.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can interact with several medicines, requiring attention to the interaction severity.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular event risk.
• Atazanavir: decreased antiviral absorption, compromising HIV treatment.
• Methotrexate: increased serum levels, raising toxicity risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR values.
• Phenytoin: possible reduction in serum concentration.
• Digoxin: may increase serum concentration.
• Diazepam: enhanced sedative effect.